SUNESIS PHARMACEUTICALS INC Human Resources Contracts & Agreements
65 Contracts & Agreements
- Bonus & Incentive Agreements (27 contracts)
- Change of Control Agreements (1)
- Compensation Agreements (7)
- Consulting Agreements (4)
- Employment Agreements (6)
- Retention Agreements (1)
- Separation Agreements (1)
- Severance Agreements (16)
- Transition Agreements (2)
- Amended and Restated Outside Director Compensation Policy (Filed With SEC on August 14, 2023)
- Consulting Agreement between the Company and Lisa Rojkjaer, M.D., dated May 5, 2023 (Filed With SEC on May 5, 2023)
- Executive Employment Agreement by and between the Company and Mark Rothera, dated September 15, 2022 (Filed With SEC on September 19, 2022)
- Separation Agreement and Release by and between the Company and Ivor Royston, dated September 15, 2022 (Filed With SEC on September 19, 2022)
- Executive Incentive Compensation Plan (Filed With SEC on March 17, 2022)
- 2021 Inducement Equity Incentive Plan and form of agreement thereunder (Filed With SEC on August 12, 2021)
- Amendment to Employment Agreement between Viracta Therapeutics, Inc. and Ivor Royston, M.D., dated August 12, 2021 (Filed With SEC on August 12, 2021)
- Amendment to Employment Agreement between Viracta Therapeutics, Inc. and Daniel Chevallard, dated August 12, 2021 (Filed With SEC on August 12, 2021)
- Amendment to Employment Agreement between Viracta Therapeutics, Inc. and Lisa Rojkjaer, M.D., dated August 12, 2021 (Filed With SEC on August 12, 2021)
- Amended and Restated Outside Director Compensation Plan (Filed With SEC on May 13, 2021)
- Form of Executive Severance Benefits Agreement between Sunesis Pharmaceuticals, Inc. and certain officers (Filed With SEC on December 22, 2020)
- Form of Retention Benefits Letter between Sunesis Pharmaceuticals, Inc. and certain officers (Filed With SEC on November 30, 2020)
- Consulting Agreement, dated May 2, 2020, by and between the Registrant and William P. Quinn (Filed With SEC on August 11, 2020)
- Executive Severance Benefits Agreement, dated May 4, 2020, by and between the Registrant and Tina Gullotta (Filed With SEC on August 11, 2020)
- Sunesis Pharmaceuticals, Inc. 2020 Bonus Program (Filed With SEC on February 14, 2020)
- Sunesis Pharmaceuticals, Inc. 2019 Bonus Program (Filed With SEC on February 4, 2019)
- Executive Severance Benefits Agreement, dated November 30, 2017, by and between the Registrant and William P. Quinn (Filed With SEC on March 9, 2018)
- Sunesis Pharmaceuticals, Inc. 2018 Bonus Program (Filed With SEC on February 5, 2018)
- Transition and Resignation Agreement, by and between Sunesis Pharmaceuticals, Inc. and Eric Bjerkholt, dated as of April 21, 2017 (Filed With SEC on July 27, 2017)
- SUNESIS PHARMACEUTICALS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Filed With SEC on May 8, 2017)
- SUNESIS PHARMACEUTICALS, INC. 2017 BONUS PROGRAM (Filed With SEC on March 27, 2017)
- Non-Employee Director Compensation Information (Filed With SEC on July 29, 2016)
- Non-Employee Director Compensation Information (Filed With SEC on May 9, 2016)
- THIRD AMENDED AND RESTATED EXECUTIVE SEVERANCE BENEFITS AGREEMENT (Filed With SEC on May 9, 2016)
- THIRD AMENDED AND RESTATED EXECUTIVE SEVERANCE BENEFITS AGREEMENT (Filed With SEC on May 9, 2016)
- SUNESIS PHARMACEUTICALS, INC. 2016 BONUS PROGRAM (Filed With SEC on March 28, 2016)
- SUNESIS PHARMACEUTICALS, INC. 2015 BONUS PROGRAM (Filed With SEC on March 23, 2015)
- SUNESIS PHARMACEUTICALS, INC. 2014 BONUS PROGRAM (Filed With SEC on March 24, 2014)
- EXECUTIVE SEVERANCE BENEFITS AGREEMENT (Filed With SEC on March 6, 2014)
- Non-Employee Director Compensation Information (Filed With SEC on August 2, 2013)
- SUNESIS PHARMACEUTICALS, INC. 2013 BONUS PROGRAM (Filed With SEC on March 27, 2013)
- SUNESIS PHARMACEUTICALS, INC. AMENDMENT TO EXECUTIVE SEVERANCE BENEFITS AGREEMENT (Filed With SEC on March 13, 2013)
- SUNESIS PHARMACEUTICALS, INC. 2012 BONUS PROGRAM (Filed With SEC on March 28, 2012)
- Exhibit A Executive Severance Benefits Agreement Exhibit B Indemnification Agreement (Filed With SEC on March 14, 2012)
- EXECUTIVE SEVERANCE BENEFITS AGREEMENT (Filed With SEC on March 14, 2012)
- SUNESIS PHARMACEUTICALS, INC. STOCK OPTION GRANT NOTICE (2011 EQUITY INCENTIVE PLAN) (Filed With SEC on March 14, 2012)
- SUNESIS PHARMACEUTICALS, INC. RESTRICTED STOCK UNIT GRANT NOTICE 2011 EQUITY INCENTIVE PLAN (Filed With SEC on March 14, 2012)
- TERMINATION AND TRANSITION AGREEMENT (Filed With SEC on May 12, 2011)
- SUNESIS PHARMACEUTICALS, INC. 2011 BONUS PROGRAM (Filed With SEC on February 18, 2011)
- SUNESIS PHARMACEUTICALS, INC. CHANGE OF CONTROL PAYMENT PLAN (Filed With SEC on July 28, 2009)
